Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

5.9%

1 terminated out of 17 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

12%

2 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed with results

Key Signals

86% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (3)
P 1 (1)
P 2 (4)
P 4 (2)

Trial Status

Completed6
Recruiting4
Not Yet Recruiting3
Unknown1
Withdrawn1
Enrolling By Invitation1

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT05350774Phase 2Enrolling By Invitation

Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2

NCT04814355Phase 4Completed

The Effect of Celecoxib on Neuroinflammation in MDD

NCT06404203Not ApplicableCompleted

The Effect of Oral Use of Lyophilised Royal Jelly on Cognitive Functions and Immune System in Elderly Individuals

NCT05129514Not ApplicableTerminated

Imaging Lymphatic/Cerebrospinal Fluid (CSF) Drainage From the Head and Neck in Persons With Traumatic Brain Injury: Demonstration of Feasibility and Evaluation of Manual Therapy to Improve Drainage and Facilitate Cognitive Recovery

NCT07424001Phase 4Completed

Preemptive IV Ibuprofen for Neurocognitive Recovery and Analgesic Needs After Inguinal Hernia Surgery

NCT06718452Not ApplicableNot Yet Recruiting

Tinnitus and Treatment With umPEA-LUT

NCT07388160Not Yet Recruiting

Neuroinflammatory Biomarkers After General Anesthesia: A Comparison Study

NCT06322342Phase 2Completed

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

NCT07269457Phase 2Not Yet Recruiting

Vitamin D3 for Moderate to Mild Traumatic Brain Injury: A Randomized Trial on Inflammation and Recovery (VIMOT)

NCT06973837Recruiting

Studying the Neurobiological Mechanisms of Non-specific Chronic Low Back Pain and Chronic Insomnia: a Four-group Cross-sectional Study

NCT06725719RecruitingPrimary

Translocator Protein PET/CT in Various TSPO-Related Disease

NCT06432023RecruitingPrimary

Imaging - Clinical Evaluation of Altered Nervous System Drainage

NCT06391866RecruitingPrimary

Neuroinflammation/Oxidative Stress/Cardiac Surgery

NCT03058328CompletedPrimary

The White Blood Cell Reactivity Following Surgical Trauma and Associated Regulatory Mechanisms.

NCT04318626Phase 2Unknown

The Influence of [18F]PMPBB3 and [18F]THK5351 PET Distribution Patterns on Post-stroke Cognitive Impairment

NCT04423471Withdrawn

Neuroinflammation, Affective and Cognitive Symptoms in Major Depression and Psoriasis

NCT03100136Phase 1CompletedPrimary

Test Re-Test Reliability of [11C]PF-06809247 as a Novel PET Tacer

Showing all 17 trials

Research Network

Activity Timeline